NO20016053L - IL-8 receptor antagonists - Google Patents

IL-8 receptor antagonists

Info

Publication number: NO20016053L
Authority: NO; Norway
Prior art keywords: receptor antagonists; antagonists; receptor
Prior art date: 1999-06-16

Application number

NO20016053A

Other languages

Norwegian (no)

Other versions

NO20016053D0 (en

Inventor

Katherine Louisa Widdowson

Daniel Frank Veber

Anthony Joseph Jurewicz

Melvin C Rutledge

Robert Philip Hertzberg

Gregory Martin Benson

Original Assignee

Smithkline Beecham Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-06-16

Filing date

2001-12-11

Publication date

2001-12-11

2001-12-11 Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp

2001-12-11 Publication of NO20016053L publication Critical patent/NO20016053L/en

2001-12-11 Publication of NO20016053D0 publication Critical patent/NO20016053D0/en

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/17—Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A61P33/06—Antimalarials
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Virology (AREA)
Physical Education & Sports Medicine (AREA)
Epidemiology (AREA)
Rheumatology (AREA)
Oncology (AREA)
Tropical Medicine & Parasitology (AREA)
Orthopedic Medicine & Surgery (AREA)
Molecular Biology (AREA)
Communicable Diseases (AREA)
Heart & Thoracic Surgery (AREA)
Diabetes (AREA)
Hematology (AREA)
Biotechnology (AREA)
Pulmonology (AREA)
Cardiology (AREA)
Vascular Medicine (AREA)
Urology & Nephrology (AREA)
Emergency Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
Heterocyclic Compounds Containing Sulfur Atoms (AREA)
Quinoline Compounds (AREA)

NO20016053A 1999-06-16 2001-12-11 IL-8 receptor antagonists NO20016053D0 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US13967599P	1999-06-16	1999-06-16
PCT/US2000/016499 WO2000076495A1 (en)	1999-06-16	2000-06-15	Il-8 receptor antagonists

Publications (2)

Publication Number	Publication Date
NO20016053L true NO20016053L (en)	2001-12-11
NO20016053D0 NO20016053D0 (en)	2001-12-11

Family

ID=22487790

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20016053A NO20016053D0 (en)	1999-06-16	2001-12-11	IL-8 receptor antagonists

Country Status (20)

Country	Link
EP (1)	EP1185261A4 (en)
JP (1)	JP2003501459A (en)
KR (1)	KR20020010709A (en)
CN (1)	CN1355697A (en)
AR (1)	AR030391A1 (en)
AU (1)	AU766083B2 (en)
BR (1)	BR0010802A (en)
CA (1)	CA2377341A1 (en)
CO (1)	CO5200760A1 (en)
CZ (1)	CZ20014471A3 (en)
HK (1)	HK1044483A1 (en)
HU (1)	HUP0201571A3 (en)
IL (1)	IL145761A0 (en)
MX (1)	MXPA01013004A (en)
NO (1)	NO20016053D0 (en)
NZ (1)	NZ514695A (en)
PL (1)	PL352232A1 (en)
TR (1)	TR200103680T2 (en)
WO (1)	WO2000076495A1 (en)
ZA (1)	ZA200109479B (en)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7521479B2 (en) *	2001-04-16	2009-04-21	Panacea Pharmaceuticals, Inc.	Methods of treating prion disease in mammals
GB0201882D0 (en) *	2002-01-28	2002-03-13	Novartis Ag	Organic compounds
US20060058395A1 (en) *	2002-08-01	2006-03-16	Neurosearch A/S	Compounds useful for the treatment of diseases responsive to antiangiogenetic therapy
KR20070011475A (en) *	2004-05-12	2007-01-24	쉐링 코포레이션	CVCR1 and CVCR2 chemokine antagonists
US7550499B2 (en)	2004-05-12	2009-06-23	Bristol-Myers Squibb Company	Urea antagonists of P2Y1 receptor useful in the treatment of thrombotic conditions
TW200600492A (en) *	2004-05-18	2006-01-01	Achillion Pharmaceuticals Inc	Substituted aryl acylthioureas and related compounds; inhibitors of viral replication
AU2005299771A1 (en)	2004-10-21	2006-05-04	High Point Pharmaceuticals, Llc	Bissulfonamide compounds as agonists of GalR1, compositions, and methods of use
US7645778B2 (en)	2005-01-19	2010-01-12	Bristol-Myers Squibb Company	Heteroaryl compounds as P2Y1 receptor inhibitors
WO2006089871A2 (en) *	2005-02-23	2006-08-31	Neurosearch A/S	Diphenylurea derivatives useful as erg channel openers for the treatment of cardiac arrhythmias
WO2007002584A1 (en)	2005-06-27	2007-01-04	Bristol-Myers Squibb Company	Linear urea mimics antagonists of p2y1 receptor useful in the treatment of thrombotic conditions
ATE485269T1 (en)	2005-06-27	2010-11-15	Bristol Myers Squibb Co	C-LINKED CYCLIC ANTAGONISTS OF THE P2Y1 RECEPTOR USEFUL IN THE TREATMENT OF THROMBOTIC DISORDERS
DE602006021306D1 (en)	2005-06-27	2011-05-26	Bristol Myers Squibb Co
WO2007002634A1 (en)	2005-06-27	2007-01-04	Bristol-Myers Squibb Company	Carbocycle and heterocycle antagonists of p2y1 receptor useful in the treatment of thrombotic conditions
US7960569B2 (en)	2006-10-17	2011-06-14	Bristol-Myers Squibb Company	Indole antagonists of P2Y1 receptor useful in the treatment of thrombotic conditions
JP2008184403A (en) *	2007-01-29	2008-08-14	Japan Health Science Foundation	Novel hepatitis C virus inhibitor
KR100982661B1 (en) *	2008-04-22	2010-09-17	전남대학교산학협력단	Pharmaceutical composition for the prevention and treatment of malaria containing a compound that inhibits plasmincin II activity as an active ingredient and a method for treating malaria using the same
KR100970940B1 (en) *	2010-05-03	2010-07-20	전남대학교산학협력단	Pharmaceutical composition for preventing and treating malaria comprising compounds that inhibit Plasmepsin II activity and the method of treating malaria using thereof
US10093617B1 (en) *	2015-10-30	2018-10-09	Sumitomo Chemical Company, Limited	Method for producing 2-amino-4-substituted phenol

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ZA921120B (en) *	1991-02-19	1993-01-27	Smithkline Beecham Corp	Cytokine inhibitors
EP0809492A4 (en) *	1995-02-17	2007-01-24	Smithkline Beecham Corp	Il-8 receptor antagonists
WO2000016768A1 (en) *	1998-09-18	2000-03-30	Smithkline Beecham Corporation	Cxcr2 inhibitors and pmn adhesion and t-cell chemotaxis

2000
- 2000-06-13 CO CO00043844A patent/CO5200760A1/en not_active Application Discontinuation
- 2000-06-14 AR ARP000102923A patent/AR030391A1/en not_active Application Discontinuation
- 2000-06-15 HK HK02106188.7A patent/HK1044483A1/en unknown
- 2000-06-15 CA CA002377341A patent/CA2377341A1/en not_active Abandoned
- 2000-06-15 WO PCT/US2000/016499 patent/WO2000076495A1/en not_active Ceased
- 2000-06-15 AU AU57413/00A patent/AU766083B2/en not_active Ceased
- 2000-06-15 JP JP2001502828A patent/JP2003501459A/en not_active Withdrawn
- 2000-06-15 CZ CZ20014471A patent/CZ20014471A3/en unknown
- 2000-06-15 HU HU0201571A patent/HUP0201571A3/en unknown
- 2000-06-15 KR KR1020017016142A patent/KR20020010709A/en not_active Withdrawn
- 2000-06-15 MX MXPA01013004A patent/MXPA01013004A/en unknown
- 2000-06-15 IL IL14576100A patent/IL145761A0/en unknown
- 2000-06-15 TR TR2001/03680T patent/TR200103680T2/en unknown
- 2000-06-15 BR BR0010802-2A patent/BR0010802A/en not_active IP Right Cessation
- 2000-06-15 PL PL00352232A patent/PL352232A1/en not_active Application Discontinuation
- 2000-06-15 NZ NZ514695A patent/NZ514695A/en unknown
- 2000-06-15 EP EP00942843A patent/EP1185261A4/en not_active Withdrawn
- 2000-06-15 CN CN00809045A patent/CN1355697A/en active Pending
2001
- 2001-11-16 ZA ZA200109479A patent/ZA200109479B/en unknown
- 2001-12-11 NO NO20016053A patent/NO20016053D0/en not_active Application Discontinuation

Also Published As

Publication number	Publication date
AU5741300A (en)	2001-01-02
JP2003501459A (en)	2003-01-14
BR0010802A (en)	2002-02-19
NZ514695A (en)	2004-05-28
CA2377341A1 (en)	2000-12-21
ZA200109479B (en)	2002-11-18
AU766083B2 (en)	2003-10-09
HUP0201571A2 (en)	2002-08-28
AR030391A1 (en)	2003-08-20
NO20016053D0 (en)	2001-12-11
WO2000076495A1 (en)	2000-12-21
MXPA01013004A (en)	2002-07-30
TR200103680T2 (en)	2002-07-22
KR20020010709A (en)	2002-02-04
EP1185261A1 (en)	2002-03-13
HK1044483A1 (en)	2002-10-25
HUP0201571A3 (en)	2002-11-28
EP1185261A4 (en)	2004-02-25
CO5200760A1 (en)	2002-09-27
CZ20014471A3 (en)	2002-08-14
PL352232A1 (en)	2003-08-11
CN1355697A (en)	2002-06-26
IL145761A0 (en)	2002-07-25

Publication	Publication Date	Title
NO20001100D0 (en)	2000-03-03	IL-8 receptor antagonists
NO20025754D0 (en)	2002-11-29	IL-8 Receptor Antagonists
ATE346043T1 (en)	2006-12-15	IL-8 RECEPTOR ANTAGONISTS
NO20016053D0 (en)	2001-12-11	IL-8 receptor antagonists
ATE299698T1 (en)	2005-08-15	IL-8 RECEPTOR ANTAGONISTS
DE60126480D1 (en)	2007-03-22	IL-8 RECEPTOR ANTAGONISTS
NO20016052D0 (en)	2001-12-11	IL-8 receptor antagonists
ATE381330T1 (en)	2008-01-15	IL-8 RECEPTOR ANTAGONISTS
DK1180028T3 (en)	2007-05-21	IL-8 receptor antagonists
MA25739A1 (en)	2003-04-01	IL-8 RECEPTOR ANTAGONISTS
DE69831413T2 (en)	2006-06-14	IL-8 RECEPTOR ANTAGONISTS
DE69824837D1 (en)	2004-08-05	IL-8 RECEPTOR ANTAGONISTS
NO20015774L (en)	2001-11-27	IL-8 receptor antagonists
NO20024367D0 (en)	2002-09-12	IL-8 receptor antagonists
NO20016065L (en)	2001-12-12	IL-8 receptor antagonists
NO20016102D0 (en)	2001-12-14	IL-8 receptor antagonists
NO20024366L (en)	2002-10-09	IL-8 receptor antagonists
NO20010353L (en)	2001-01-22	IL-8 receptor antagonist
SE0003996D0 (en)	2000-11-01	receptor Antagonists

Legal Events

Date	Code	Title	Description
2006-01-30	FC2A	Withdrawal, rejection or dismissal of laid open patent application